Rational Development of Peptide Vaccination in Clinical Oncology. Concerning Jäger E, et al.: Peptide vaccination in clinical oncology. Onkologie 2000;23:410–415.

Publisher： Karger

E-ISSN： 2296-5262|24|2|174-174

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.2, 2001-05, pp. : 174-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology

By Qin Rui   Kohli Manish  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 859-869

Future Medicine

Access to resources Recommend Favorite

Treatment of Metastatic Renal Cell Carcinoma: How Reliable are Small Non-Randomised Clinical Trials? Concerning Mross et al.: Onkologie 1999;22:412–415.

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 520-520

Karger

Access to resources Recommend Favorite

Micrometastases and Microinvolvement in Esophageal Carcinoma. Concerning Feith et al.: Clinical relevance of lymph node micrometastases in esophageal carcinoma. Onkologie 2000;23:330–333

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 478-479

Karger

Access to resources Recommend Favorite

Impact of Pharmacogenomics on Clinical Practice in Oncology

By Marsh Sharon  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 79-82

Adis International

Access to resources Recommend Favorite

Magnetic Resonance Spectroscopy in Clinical Oncology

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 304-309

Karger

Access to resources Recommend Favorite